Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3 scaffold
Details
Publication Year 2025,Volume 15,Issue #5,Page 2035-2051
Journal Title
Theranostics
Abstract
The Ser/Thr kinase RAF, particularly BRAF isoform is a dominant target of oncogenic mutations and many mutations have been identified in various cancers. However, how these mutations except V600E evade the regulatory machinery of RAF protein and hence trigger its oncogenicity remains unclear.
Publisher
Ivyspring International Publisher
Research Division(s)
Cancer Biology And Stem Cells
Open Access at Publisher's Site
https://doi.org/10.7150/thno.103958
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-02-07 02:57:20
Last Modified: 2025-02-07 03:13:23
An error has occurred. This application may no longer respond until reloaded. Reload 🗙